Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KFORCE INCKFRC · Entity 4963 | Director | March 06, 2020 | March 10, 2020 |
| Tabula Rasa HealthCare, Inc.TRHC · Entity 108300 | Director | June 10, 2022 | June 14, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KFORCE INC
Report date March 06, 2020 · Filed March 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,034 |
Reported balance
After 2020-03-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-03-06 · Other · Acquired 17 · Balance 4,034 F1: The transaction is disclosing a dividend that is exempt from reporting under Rule 16a. F2: On January 31, 2020, the issuer declared a cash dividend of $0.20 per share of common stock, payable March 20, 2020 to all shareholders of record on March 6, 2020 (the "Dividend"). The additional shares of restricted stock were received by the reporting person in connection with the Dividend and will vest in accordance with the terms of the reporting person's outstanding restricted stock agreement(s). F3: Includes 2,760 shares of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction is disclosing a dividend that is exempt from reporting under Rule 16a.
F2: On January 31, 2020, the issuer declared a cash dividend of $0.20 per share of common stock, payable March 20, 2020 to all shareholders of record on March 6, 2020 (the "Dividend"). The additional shares of restricted stock were received by the reporting person in connection with the Dividend and will vest in accordance with the terms of the reporting person's outstanding restricted stock agreement(s).
F3: Includes 2,760 shares of restricted stock.
Tabula Rasa HealthCare, Inc.
Report date June 10, 2022 · Filed June 14, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 88,334 |
Reported balance
After 2022-06-10 transaction · row 1
1 source rowRow 1 · 2022-06-10 · Grant · Acquired 46,377 · Balance 88,334 F1: The reporting person received a restricted stock award of 46,377 shares of the Company's common stock on June 10, 2022. Such common stock will vest in full on the one-year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a restricted stock award of 46,377 shares of the Company's common stock on June 10, 2022. Such common stock will vest in full on the one-year anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2016 Filed Jan 17, 2018 18:33 UTC Amendment | Tabula Rasa HealthCare, Inc. TRHC · Entity 108300 | GrantEmployee Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $14.23 | $0.00 |
DisclosureSEC source: 0001179110-18-000929 · edgar.xml · derivative · entry 1 TUNSTALL GORDON · CIK 0001219799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-10-21 F1 · derivative.exercise_date: Previous disclosure stated one-third of the option award will vest on October 21, 2017 and in equal 1/36th installments each month thereafter. Notwithstanding the foregoing, one third of the option award vested on October 21, 2017 and the option award has vested and will continue to vest in 1/24th installments each month thereafter. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 20:27 UTC | KFORCE INC KFRC · Entity 4963 | OtherCommon Stock | 34 | $0.00 | $0.00 |
DisclosureSEC source: 0000930420-16-000529 · wf-form4_147379846327489.xml · nonDerivative · entry 1 TUNSTALL GORDON · CIK 0001219799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,928 F1 · kind: The transaction is disclosing a dividend that is exempt from reporting under Rule 16a. F2 · shares: On July 29, 2016, the issuer declared a cash dividend of $0.12 per share of common stock, payable September 23, 2016 to all shareholders of record on September 9, 2016 (the "Dividend"). In accordance with the terms of the Restricted Stock Agreement dated April 29, 2016, 34 additional shares of restricted stock were received by the reporting person in connection with the Dividend. The additional shares of restricted stock will vest on April 29, 2017. F3 · balance_after: Includes 5,328 shares of restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.